Matches in Nanopublications for { ?s ?p "[The phase II SRC/ABL Tyrosine Kinase Inhibition Activity Research Trials (START) of dasatinib have established dasatinib as potent and effective in overcoming imatinib resistance or intolerance in all phases of CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP271758.RAd40AwIKxViTRYPLsv0CqIkZLG6Ns2nl9jU61sdfOdsI130_assertion description "[The phase II SRC/ABL Tyrosine Kinase Inhibition Activity Research Trials (START) of dasatinib have established dasatinib as potent and effective in overcoming imatinib resistance or intolerance in all phases of CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP271758.RAd40AwIKxViTRYPLsv0CqIkZLG6Ns2nl9jU61sdfOdsI130_provenance.
- assertion description "[The phase II SRC/ABL Tyrosine Kinase Inhibition Activity Research Trials (START) of dasatinib have established dasatinib as potent and effective in overcoming imatinib resistance or intolerance in all phases of CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP711948.RAxEg8cjIZ8rKYIACH2J7nmNikMrpHzJ4NtPwmq73wPjM130_assertion description "[The phase II SRC/ABL Tyrosine Kinase Inhibition Activity Research Trials (START) of dasatinib have established dasatinib as potent and effective in overcoming imatinib resistance or intolerance in all phases of CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711948.RAxEg8cjIZ8rKYIACH2J7nmNikMrpHzJ4NtPwmq73wPjM130_provenance.
- NP664683.RA-DlcvjSYty5kp4E_Xt8ksckeQx4RtfkOq03PYN5bQrg130_assertion description "[The phase II SRC/ABL Tyrosine Kinase Inhibition Activity Research Trials (START) of dasatinib have established dasatinib as potent and effective in overcoming imatinib resistance or intolerance in all phases of CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664683.RA-DlcvjSYty5kp4E_Xt8ksckeQx4RtfkOq03PYN5bQrg130_provenance.